LOADING

Type to search

Moderna Develops New CCP Virus Vaccine for South African Variant

AMERICA CCP Virus Health Education Health News Mind & Body Moderna PUBLIC HEALTH INFORMATION South Africa US Vaccine

Moderna Develops New CCP Virus Vaccine for South African Variant

Share

Moderna announced on Jan. 25 that it had developed a new CCP virus vaccine to combat a new South African variant of the virus, with plans to advance it into a phase one study. “Out of an abundance of caution and leveraging the flexibility of our mRNA platform, we are advancing an emerging variant booster candidate against the variant first identified in the Republic of South Africa into the clinic to determine if it will be more effective to boost titers [antibody levels] against this and potentially future variants,” Moderna’s Chief Executive Officer Stéphane Bancel said in a statement. The company says that the development of the new vaccine was important in the fight against the CCP (Chinese Communist Party) virus, which causes the disease COVID-19, especially “as the virus evolves.” First detected in South Africa, the B.1.351 variant, along with another variant first identified in the United Kingdom, spreads faster and is …

Leave a Comment

Your email address will not be published. Required fields are marked *